Peter N. Dorff

Synthesis of 6‐acrylamido‐4‐(2‐[¹⁸F]fluoroanilino)quinazoline: a prospective irreversible EGFR binding probe

Neil Vasdev, Peter N. Dorff, Andrew R. Gibbs et al. · Journal of Labelled Compounds and Radiopharmaceuticals · 2004 · 48 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +14

A New Strategy for Preparing Molecular Imaging and Therapy Agents Using Fluorine-Rich (Fluorous) Soluble Supports

Amanda C. Donovan, Jane Forbes, Peter N. Dorff et al. · Journal of the American Chemical Society · 2006 · 44 citations

Medicine, Medicinal Chemistry, Biomedical Imaging +16

Metabolic stability of 6,7-dialkoxy-4-(2-, 3- and 4-[18F]fluoroanilino)quinazolines, potential EGFR imaging probes

Neil Vasdev, Peter N. Dorff, James P. O’Neil et al. · Bioorganic & Medicinal Chemistry · 2011 · 22 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +14

Investigation of isotopic exchange reactions using <i>N</i>‐heterocyclic iridium (I) complexes

Mark Powell, Charles S. Elmore, Peter N. Dorff et al. · Journal of Labelled Compounds and Radiopharmaceuticals · 2007 · 20 citations · Full text

Natural Sciences, Chemistry, Inorganic Chemistry +9

Radiochemical synthesis and in vivo evaluation of [18F]AZ11637326: An agonist probe for the α7 nicotinic acetylcholine receptor

Hayden T. Ravert, Peter N. Dorff, Catherine A. Foss et al. · Nuclear Medicine and Biology · 2013 · 19 citations

Medicine, Medicinal Chemistry, Pharmacology +17